116 related articles for article (PubMed ID: 6265032)
1. Thyrotropin-releasing hormone (TRH) content of rat striatum: modification by drugs and lesions.
Spindel ER; Pettibone DJ; Wurtman RJ
Brain Res; 1981 Jul; 216(2):323-31. PubMed ID: 6265032
[TBL] [Abstract][Full Text] [Related]
2. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
Narumi S; Nagawa Y
Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
[TBL] [Abstract][Full Text] [Related]
3. The effects of repeated amphetamine administration on the thyrotropin-releasing hormone level. Its release and receptors in the rat brain.
Jaworska-Feil L; Budziszewska B; Lasón W
Neuropeptides; 1995 Sep; 29(3):171-6. PubMed ID: 8538879
[TBL] [Abstract][Full Text] [Related]
4. D-Amphetamine reduces striatal substance P concentrations by presynaptic release of dopamine.
Pettibone DJ; Wurtman RJ
Brain Res; 1980 Mar; 186(2):409-19. PubMed ID: 6153555
[TBL] [Abstract][Full Text] [Related]
5. Reduction of rat striatal thyrotropin-releasing hormone receptors produced by repeated methamphetamine administration.
Nakashima M; Kajita S; Otsuki S
Biol Psychiatry; 1989 Jan; 25(2):191-9. PubMed ID: 2539202
[TBL] [Abstract][Full Text] [Related]
6. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
7. The effects of thyrotropin releasing hormone on rats with lesions of the mesolimbic and nigrostriatal dopamine systems.
Andrews JS; Sahgal A
Physiol Behav; 1985 Jul; 35(1):93-7. PubMed ID: 2997819
[TBL] [Abstract][Full Text] [Related]
8. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
Roger LJ; Breese GR; Morell P
Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
[TBL] [Abstract][Full Text] [Related]
9. The effects of single and repeated morphine administration on the level of thyrotropin-releasing hormone and its receptors in the rat brain.
Jaworska-Feil L; Budziszewska B; Lasoń W
Neuropeptides; 1995 Dec; 29(6):343-9. PubMed ID: 8837962
[TBL] [Abstract][Full Text] [Related]
10. Effects of repeated cocaine administration on the thyrotropin-releasing hormone level and receptors in the rat brain.
Jaworska-Feil L; Budziszewska B; Lasoń W
Neuropeptides; 1997 Jun; 31(3):253-8. PubMed ID: 9243522
[TBL] [Abstract][Full Text] [Related]
11. Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats.
Nash JF; Yamamoto BK
Brain Res; 1993 Nov; 627(1):1-8. PubMed ID: 7904885
[TBL] [Abstract][Full Text] [Related]
12. Localization of thyrotropin-releasing hormone (TRH) receptors in the septal nucleus of the rat brain.
Simasko SM; Horita A
Brain Res; 1984 Apr; 296(2):393-5. PubMed ID: 6322932
[TBL] [Abstract][Full Text] [Related]
13. Effects of pilocarpine- and kainate-induced seizures on thyrotropin-releasing hormone biosynthesis and receptors in the rat brain.
Jaworska-Feil L; Turchan J; Przewłocka B; Budziszewska B; Leśkiewicz M; Lasoń W
J Neural Transm (Vienna); 1999; 106(5-6):395-407. PubMed ID: 10443546
[TBL] [Abstract][Full Text] [Related]
14. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
Yamada K; Demarest KT; Moore KE
Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
[TBL] [Abstract][Full Text] [Related]
15. Repeated treatment with amitriptyline or electroconvulsive shock does not affect thyrotropin releasing hormone receptors in discrete rat brain structures.
Przegalinski E; Jaworska L; Konarska R
Neurosci Lett; 1990 Jul; 115(1):86-91. PubMed ID: 2170869
[TBL] [Abstract][Full Text] [Related]
16. Chemical and surgical lesions of rat olfactory bulb: changes in thyrotropin-releasing hormone and other systems.
Sharif NA
J Neurochem; 1988 Feb; 50(2):388-94. PubMed ID: 2826693
[TBL] [Abstract][Full Text] [Related]
17. [Thyrotropin-releasing hormone (TRH): action mechanism of an enhanced dopamine release from rat striatal slices (author's transl)].
Narumi S; Nagai Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1979 Apr; 75(3):239-50. PubMed ID: 119692
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic substrates of amphetamine-induced place preference conditioning.
Spyraki C; Fibiger HC; Phillips AG
Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
[TBL] [Abstract][Full Text] [Related]
19. Changes in brain thyrotropin-releasing hormone (TRH) of seizure-prone El mice.
Yamashita K; Mori A; Otsuki S
Exp Neurol; 1990 Apr; 108(1):71-5. PubMed ID: 2156726
[TBL] [Abstract][Full Text] [Related]
20. Alteration of calmodulin distribution does not accompany dopaminergic supersensitization of the mouse striatum.
May PC; Osterburg HH; Mandel RJ; Morgan DG; Randall PK; Finch CE
J Neurosci Res; 1987; 17(3):247-50. PubMed ID: 3037094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
